Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

0.928
Delayed Data
As of Apr 27
 -0.0276 / -2.89%
Today’s Change
0.51
Today|||52-Week Range
3.72
+32.59%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close0.96
Today’s open1.00
Day’s range-- - --
Volume317,313
Average volume (3 months)1,160,063
Market cap$32.9M
Dividend yield--
Data as of 04/27/2015

Growth & Valuation

Earnings growth (last year)+30.47%
Earnings growth (this year)-7.87%
Earnings growth (next 5 years)--
Revenue growth (last year)+59.96%
P/E ratioNM
Price/Sales8.86
Price/Book1.02

Competitors

 Today’s
change
Today’s
% change
SKBISkystar Bio-Pharmace...+0.14+3.67%
OGENOragenics Inc-0.02-2.46%
ACURAcura Pharmaceutical...+0.01+1.31%
ALXAAlexza Pharmaceutica...-0.02-1.03%
Data as of 04/27/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$1.7M
Annual profit (last year)-$19.4M
Net profit margin-1,119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers